Bullish
FDA grants Orphan Drug status to Immutep's sarcoma therapy
Immutep (ASX:IMM) has received Orphan Drug Designation from the FDA for its lead product candidate, eftilagimod alfa, to treat soft tissue sarcoma. Th...
IMMP
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (1)
Neutral (0)
Bearish (0)
Latest IMMP News
Bullish
Research IMMP on:
Ad Space